Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2008-05-20
2011-11-29
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S169000
Reexamination Certificate
active
08067400
ABSTRACT:
A method of improving cumulative embryo score may comprise administering an androgen to a human female for at least about four consecutive months followed by harvesting and fertilizing oocytes and forming embryos. A method of increasing the quantity of fertilized oocytes in one cycle of in vitro fertilization may comprise administering an androgen to a human female for at least about four consecutive months, harvesting and fertilizing the oocytes. A method of normalizing ovarian DHEA may include administering an androgen for at least about four consecutive months. A method of decreasing the time to pregnancy and increasing the rate of pregnancy by administering an androgen for at least about two months. A method of decreasing miscarriage rates may comprise administering an androgen for at least about two months to a female. Moreover, a method of decreasing aneuploidy rates in human embryos may comprise administering an androgen to a female for at least about two months.
REFERENCES:
patent: 4670401 (1987-06-01), Cutler et al.
patent: 4931403 (1990-06-01), Cutler et al.
patent: 6221857 (2001-04-01), Vandenbergh et al.
patent: 6352997 (2002-03-01), Waldstreicher et al.
patent: 6548087 (2003-04-01), Kent et al.
patent: 2006/0141499 (2006-06-01), Sher et al.
patent: 2007/0155710 (2007-07-01), Gleicher et al.
patent: 2007/0178478 (2007-08-01), Dhallan et al.
International Searching Authority, PCT International Search Report and Written Opinion, International Application No. PCT/US09/42702, Jun. 22, 2009.
Barbieri RL, et al. Association of body mass index, age, and cigarette smoking with serum testosterone levels in cycling women undergoing in vitro fertilization. Fertil Steril 2005; 83(2):302-8.
Macklou NS, Fauser BC. Aspects of ovarian follicle development throughout life. Horm Res 1999; 52:161-70.
Gleicher N, et al. Preliminary evidence that dehydroepiandrosterone (DHEA) increases the chance for the transfer of euploid embryos in women with diminished ovarian reserve.
Gleicher N, Barad DH. The effect of dehydroepiandrosterone on diminished ovarian reserve. Hum Reprod 2006; 21(S-1) i69.
Barad Dh, Gleicher N. The effect of dehydroepiandrosterone (DHEA) on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 2006;21:2845-9.
Brill H, et al. Dehydroepiandrosterone (DHEA) supplementation and pregnancy outcome: Effect on pregnancy rate and speed of conception. Fertil Steril 2006 (Suppl 1), In press.
Lossi K, et al. Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols. Hum Reprod Advanced Access, Jun. 19, 2006.
Hsueh AJ, et al. Gonadal cell apoptosis. Recent Prog Horm Res 1996; 51:433-55.
Weghofer A, et al. Aneuploidy rates in embryos from women with prematurely declining ovarian function. Fertil Steril, in revision.
Munne S, et al. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities Fertil Steril 1995; 64:382-91.
Wu JM, et al. Ovarian aging and menopause: current theories, hypotheses, and research models. Exp Biol Med 2005; 230:818-28.
Munne S, et al. Referring Centers PGD Group. Preimplantation genetic diagnosis significantly reduces pregnancy loss in infertile couples: a multicenter study. Fertil Steril 2005; 85:326-32.
Barad DH, et al. Evidence towards an empiric definition of premature aging ovaries. Fertil Steril (Suppl 1), In press.
Gleicher N, Barad D. Premature ovarian aging and ovarian resistance in young women. Clinical profile and IVF outcome. Fertil Steril, In press.
Taranissi M, et al. Influence of maternal age on the outcome of PGD for aneuploidy screening in patients with recurrent implantation failure. Reprod Biomed Online 2005; 10:628-32.
McNatty KP, et al. The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulose cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 1979; 49:851-60.
Andersen CY. Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J Clin Endocinol Metab 1993; 77:1227-34.
Hillier SG, et al. Location and developmental regulation of androgen receptor in primate ovary. Hum Reprod 1997; 12:107-11.
Weil S, et al. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999; 84:2951-6.
Gleicher N, et al. Does female androgenization affect the gender offspring.
Grant VJ. Sex predetermination and the ethics of sex selection. Hum Reprod 2006; 21:1659-61.
Hardy ICW. The birds and the wasps: a sex ratio meta-analysis. Trend Ecol Evol 2002; 17:207.
Conover Do, Van Voorhees DA. Evolution of a balanced sex ratio by frequency-dependent selection in a fish. Science, Dec. 1990, vol. 250; 1556-8.
Komdeur J, et al. pre-ovulation control of hatchling sex ratio in the Seychelle warbles. Proc Biol Sci 2002; 269:1967-72.
Veiga JP, et al. Experimentally increased testosterone affects social rank and primary sex ratio in the spotless starling. Horm Behave 2004; 46:47-53.
Krackow S. Potential mechanisms for sex ratio adjustment in mammals and birds. Biol Rev Camb Philos Soc 1995; 70:225-41.
Bouissou MF. Effects of testosterone proprionate on dominance relationships in a group of cows. Horm Behav 1978; 11:388-400.
Udry Jr, et al. Androgen effects on women's gendered behaviour. J Bisoc Sci 1995; 27:359-368.
Grant VJ, France JT. Dominance and testosterone in women. Biol Psychol 2001; 58: 41-47.
Grant VJ, Irwin RJ. Follicular fluid steroid levels and subsequent sex of bovine embryos. J Exp Zool 2005; 303A:1120-5.
Barad DH, Gleicher N. Dehydroepiandrosterone (DHEA) increases pregnancy rates in women with diminished ovarian reserve; a case controlled study. Fertil Steril Submitted for publication.
Azziz R, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004; 89:453-62.
Gleicher N. An evolutionary concept of polycystic ovarian disease: does evolution favour reproductive success over survival? Reprod Biomed Online 2006; 12:587-9.
Hofmann, GE et al. High-dose follicule-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization. Journal of in vitro Fertilization and Embryo Transfer, 1989, 6, 285-289.
Surrey, ES et al. Clinical and endocrine effects of amicrodose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril, 1998, 69, 419-424.
Damario, Ma et al. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in vitro fertilization outcome in high responder patients. Human Reproduction, 1997, 12, 2359-65.
Visser et al. The applicability of the cumulative embryo score system for embryo selection and quality control in an in-vitro fertilization/embryo transfer programme. Human Reproduction, 1993, 8, 1719-1722.
Lutz, et al. Evidence that androgens are the primary steroids produced by Xenopus laevis ovaries and may signal through the classical androgen receptor to promote oocyte maturation. PNAS, 2001, 98, 13728-13733.
Hammes Sr. Steroids and oocyte maturation—a new look at an old story. Molecular Endocrinology, 2004, 18(4), 769-775 (mini review).
Genazzani, et al. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women. Fertility and Sterility, 2001, 76, 241-248.
Morales, et al. Effects of Replacement Dose of Dehydroepiandrosterone in Men and Women of Advancing Age. Journal of Clinical Endocrinology and Metabolism, 1994, 78, 6, 1360-1367.
Muasher SJ. Treatment of low responders. Journal of Assisted Reproduction and Genetics, 1993, 10, 112-114.
Gleicher N, Barad D. Race-based fertility therapy. 2005. Submitted for publication.
Speroff L, et al. Normal and abnormal sexual development. Idem 1999a, pp. 339-379.
Speroff L, et al. Amenorrhea. Idem 1999b, pp.
Barad David H.
Gleicher Norbert
Harben Dwyn V.
American Infertility of New York
Beem Patent Law Firm
Hirt Erin
Richter Johann
LandOfFree
Androgen treatment in females does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Androgen treatment in females, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Androgen treatment in females will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4288945